Explainable Boosting Machine in Sepsis Prediction Using Platelet Metabolomics: An Interpretable Machine Learning Approach
Diagnostics · 27.05.2026 · 16 (11) · 1643
DOI: 10.3390/diagnostics16111643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 27.05.2026. Verfasst von Emek Guldogan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, and Medical Informatics, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University.
Abstract (Originalsprache)
Background
Sepsis remains a leading cause of mortality in emergency and intensive care settings, with early diagnosis representing a critical determinant of patient outcomes. Despite advances in biomarker discovery, integrating platelet-derived metabolic signatures with explainable machine learning frameworks for sepsis prediction remains underexplored. The clinical adoption of predictive models has been hindered by the “black box” nature of conventional algorithms, limiting clinician trust and understanding.
Objective
This study aimed to evaluate and validate an interpretable machine learning model utilizing platelet metabolomics data for accurate sepsis prediction while providing clinically meaningful explanations of the underlying metabolic disturbances that could inform therapeutic decision-making.
Methods
We analyzed metabolomics data, comprising 25 sepsis patients diagnosed according to Sepsis-3 criteria and 14 age- and gender-matched non-sepsis from the emergency department. Platelet metabolite profiles were obtained via quantitative 1H-NMR spectroscopy. Five machine learning algorithms were evaluated: Explainable Boosting Machine (EBM), Support Vector Machine (SVM), Logistic Regression (LR), Gradient Boosting Machine (GBM), and AdaBoost. Three biologically motivated metabolite ratios (adenosine triphosphate/adenosine diphosphate (ATP/ADP), ATP/adenosine monophosphate (AMP), Glutamine/Glutamate) were derived as additional features, yielding 22 candidate variables. Models were evaluated using a fully nested leave-one-out cross-validation (LOOCV) framework in which log transformation, KNN imputation, BorderlineSMOTE class balancing, and hyperparameter optimisation were performed exclusively within each training fold. Global and local interpretability analyses were performed to identify discriminative metabolites.
Results
EBM achieved the highest ROC-AUC (0.864; 95% CI: 0.736–1.000), the highest PR-AUC (0.902; 95% CI: 0.783–0.997), and the best Brier score (0.189; 95% CI: 0.130–0.258) among all evaluated models, with sensitivity 0.880 (95% CI: 0.640–1.000; TP = 22/25) and specificity 0.714 (95% CI: 0.357–1.000; TN = 10/14). Global feature importance identified Carnitine, myo-Inositol, ADP, and O-Phosphoethanolamine as the leading single-feature predictors, alongside three pairwise interaction terms reflecting non-additive energy–amino acid metabolic relationships. Local explanations demonstrated that the ADP–Creatine interaction, Glutamine, and myo-Inositol drove correct sepsis classification in a representative true positive case.
Conclusions
The EBM model demonstrated the highest discriminative performance and best calibration among all evaluated models, providing transparent mechanistic insights through global feature importance, and patient-level local explanations. These findings position the proposed framework as a proof-of-concept warranting external validation in larger, multi-centre cohorts before any clinical application is considered.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biostatistics, and Medical Informatics, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
- Department of Family Medicine, Faculty of Medicine, Malatya Turgut Ozal University, 44210 Malatya, Türkiye.
- Department of Computer Sciences, College of Computer and Information Sciences, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
- Department of Physiology, College of Medicine, King Khalid University, Abha 61421, Saudi Arabia.
- Department of Biostatistics, Faculty of Medicine, Malatya Turgut Ozal University, 44210 Malatya, Türkiye.
ORCID-Profile: Emek Guldogan, Burak Yagin, Yavuz Korkmaz, Amal K Alkhalifa, Fahaid Al-Hashem, Fatma Hilal Yagin
Förderung
- Princess Nourah bint Abdulrahman University
Zitieren
APA
Guldogan, E., Yagin, B., Korkmaz, Y., Alzakari, S. A., Alkhalifa, A. K., Al-Hashem, F., & Yagin, F. H. (2026). Explainable Boosting Machine in Sepsis Prediction Using Platelet Metabolomics: An Interpretable Machine Learning Approach. Diagnostics, 16(11), 1643. https://doi.org/10.3390/diagnostics16111643
Vancouver
Guldogan E, Yagin B, Korkmaz Y, Alzakari SA, Alkhalifa AK, Al-Hashem F, et al. Explainable Boosting Machine in Sepsis Prediction Using Platelet Metabolomics: An Interpretable Machine Learning Approach. Diagnostics. 2026;16(11):1643. doi:10.3390/diagnostics16111643
BibTeX
@article{Guldogan2026,
author = {Guldogan, Emek and Yagin, Burak and Korkmaz, Yavuz and Alzakari, Sarah A and Alkhalifa, Amal K and Al-Hashem, Fahaid and Yagin, Fatma Hilal},
title = {Explainable Boosting Machine in Sepsis Prediction Using Platelet Metabolomics: An Interpretable Machine Learning Approach},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {11},
pages = {1643},
doi = {10.3390/diagnostics16111643}
}
EUVIMED